Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
about
Clozapine: a review of clinical practice guidelines and prescribing trendsA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyAntipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.Clozapine prescribing in a Canadian outpatient population.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.Clozapine reinitiation following a "red result" secondary to chemotherapy.Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trialPrescribing pattern of clozapine and other antipsychotics for patients with first-episode psychosis: a cross-sectional survey of early intervention teams.Where to position clozapine: re-examining the evidence.Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Treatment resistance and other complicating factors in the management of schizophrenia.Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.Clozapine use and outcomes among patients with treatment resistant schizophrenia.
P2860
Q21260307-EA2A797D-6895-4B94-80A1-7FF5E5B05C4DQ30485065-8AFD59B0-86C4-4CA2-97AF-FE0F748BBBCDQ33560808-1DF648A3-C25A-4D5E-9A43-F3B36B392D2BQ34544343-B7CFB9DA-39FA-44B9-A398-708A15A61C00Q35073113-D04741DF-DCC9-4EB2-B563-6C1FE97D1EC8Q35906545-632622BA-8BC7-4936-8382-BBD0C704B9F5Q37160727-74AFA5A8-A3F5-4461-9330-95E146AD8198Q37212118-C9987D20-005D-4D8F-832A-2057454C85CCQ37705255-3334C7B6-B329-4460-BC82-246564B2A5EFQ37801988-E1515DCF-3F56-4236-A00F-214631C04ACDQ38062444-46CDC2C6-63E1-4D2C-9D42-3A691452D9E3Q38269768-BF954B72-364A-4EBB-BF28-E5AC7267A761Q38721556-ED2AD0FE-8AC1-45C1-86F7-6CDF0A27A8DFQ38840211-4B7CB32D-3D59-4240-92EB-C70C7E6B3EDEQ38867008-0D847523-DC51-45D4-8796-FE16710CB28AQ50134375-C2DCD972-2A61-4003-B31B-EBAE0A1A82BDQ50501799-28BE5C2E-EA9D-41DF-9DB7-806EB6DB0AADQ50618508-3321CDA2-FB0A-43DA-8D93-603B57D2141AQ50789500-8A46466D-B004-4D8C-9537-20CD5816699C
P2860
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@en
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@nl
type
label
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@en
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@nl
prefLabel
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@en
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
@nl
P2860
P356
P1476
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand
@en
P2093
Amanda J Wheeler
P2860
P304
P356
10.1345/APH.1K662
P407
P577
2008-05-13T00:00:00Z